Saluda Medical, Inc. Stock: price and insider trades · Australia
Saluda Medical, Inc.: what insiders have been doing
Saluda Medical, Inc. belongs to the Health Care sector. Filings by its managers are published through ASX. The last twelve months, up to 27 October 2026, brought 4 filings signed by 4 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
No insider has bought Saluda Medical, Inc. shares on the open market in the past twelve months.
For context, the typical company on the same exchange (median of 1,602 companies) published 5 filings over the same period, against 4 filings here.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Saluda Medical, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: A$1.66.
Financial data
· cache
- ShareASXASX:2924-03139250-2A1698948
- ShareASXASX:2924-03134984-2A1696869
- ShareASXISIN AU0000432114ASX:2924-03128447-2A1693332
- ShareASXISIN AU0000432114ASX:2924-03110453-2A1684133
4 of 4 declarations
About Saluda Medical, Inc.
Saluda Medical, Inc. is a company focused on developing innovative medical technologies for the treatment of chronic pain. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations